HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
A Hasenburg Selected Research
A Hasenburg Research Topics
Disease
16
Breast Neoplasms (Breast Cancer)
07/2020 - 09/2005
12
Ovarian Neoplasms (Ovarian Cancer)
09/2021 - 06/2000
12
Neoplasms (Cancer)
09/2021 - 12/2000
4
Neoplasm Metastasis (Metastasis)
09/2017 - 09/2005
4
Carcinoma (Carcinomatosis)
09/2012 - 01/2007
3
Ovarian Epithelial Carcinoma
09/2021 - 01/2002
1
Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
11/2012
1
Myalgia
10/2012
1
Arthralgia (Joint Pain)
10/2012
1
Pleural Effusion (Pleural Effusions)
09/2012
1
Brain Neoplasms (Brain Tumor)
11/2010
1
Bone Resorption
06/2009
1
Residual Neoplasm
11/2005
1
Ascites
11/2005
1
Ileus
03/2005
1
Cysts
03/2005
1
Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2005
1
Disease Progression
08/2004
1
Respiratory Tract Infections (Respiratory Tract Infection)
08/2004
1
Herpes Simplex
01/2002
1
Thrombocytosis (Thrombocythemia)
06/2000
Drug/Important Bio-Agent (IBA)
6
Tamoxifen
FDA Link
Generic
01/2018 - 06/2009
6
exemestane (Aromasin)
FDA Link
01/2018 - 06/2009
5
Hormones (Hormone)
IBA
07/2020 - 07/2009
5
Platinum
IBA
09/2012 - 08/2004
4
Proteins (Proteins, Gene)
FDA Link
09/2021 - 09/2005
4
Messenger RNA (mRNA)
IBA
09/2017 - 09/2005
4
Thymidine Kinase
IBA
05/2002 - 06/2000
4
Topotecan (Hycamtin)
FDA Link
Generic
05/2002 - 06/2000
3
Aromatase Inhibitors
IBA
10/2013 - 06/2009
2
Biomarkers (Surrogate Marker)
IBA
09/2021 - 12/2014
2
4-amino-4'-hydroxylaminodiphenylsulfone (HADS)
IBA
11/2012 - 12/2000
2
taxane
IBA
01/2012 - 01/2007
2
Formaldehyde (Formol)
FDA Link
11/2009 - 01/2007
2
Paraffin
IBA
11/2009 - 01/2007
2
DNA (Deoxyribonucleic Acid)
IBA
01/2007 - 01/2002
2
Prodrugs
IBA
01/2002 - 06/2000
1
Tumor Biomarkers (Tumor Markers)
IBA
09/2021
1
Leptin
IBA
09/2021
1
Prolactin
IBA
09/2021
1
human ERBB2 protein
IBA
07/2020
1
Dihydrotachysterol (AT 10)
IBA
01/2018
1
Interferons
IBA
07/2017
1
Epidermal Growth Factor (EGF)
IBA
10/2013
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
09/2012
1
Sunitinib (Sutent)
FDA Link
09/2012
1
Aurora Kinases
IBA
01/2012
1
Procollagen Type I
IBA
06/2009
1
Alkaline Phosphatase
IBA
06/2009
1
Osteocalcin
IBA
06/2009
1
Collagen Type I (Type I Collagen)
IBA
06/2009
1
Aurora Kinase A
IBA
01/2007
1
vasectrin III
IBA
11/2005
1
Focal Adhesion Protein-Tyrosine Kinases
IBA
09/2005
1
Integrin alphaVbeta3
IBA
05/2002
1
Integrins
IBA
05/2002
1
Valacyclovir (Valtrex)
FDA Link
Generic
05/2002
1
integrin alphaVbeta5
IBA
05/2002
1
Coxsackie and Adenovirus Receptor-Like Membrane Protein
IBA
05/2002
1
Acyclovir (Aciclovir)
FDA Link
Generic
05/2002
1
Integrin alpha Chains
IBA
03/2001
1
adenovirus receptor
IBA
03/2001
1
Alanine Transaminase (SGPT)
IBA
06/2000
Therapy/Procedure
12
Therapeutics
10/2019 - 08/2004
10
Drug Therapy (Chemotherapy)
07/2020 - 06/2000
2
Radiotherapy
01/2016 - 03/2005
1
Complementary Therapies (Alternative Medicine)
11/2012
1
Neoadjuvant Therapy
09/2012
1
Cytoreduction Surgical Procedures
11/2005
1
Lymph Node Excision (Lymph Node Dissection)
03/2005
1
Hysterectomy
03/2005
1
Critical Care (Surgical Intensive Care)
08/2004
1
Total Parenteral Nutrition
08/2004
1
Second-Look Surgery
12/2001